Clinical trial
Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to…
NCT00028964 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00028964 |
|---|---|
| Title | Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer |
| Official title | A Randomized, Double Blind, Pacebo-Controlled Study to Assess The Feasibility, Toxicity And Efficacy (Phase I/II) Of A Chinese Herbal Therapy (CHT) For Symptom Management In Women Undergoing Chemotherapy For Stage I/II/III Breast Cancer |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Drug/Agent Toxicity by Tissue/Organ |
| Intervention type | Dietary Supplement, Drug, Procedure |
| Interventions | Chinese herbs, cyclophosphamide, doxorubicin hydrochloride, adjuvant therapy |
| Start date | Feb 1, 2001 |
| Completion | Feb 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 23, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: